The Identification by Shotgun Proteomics with High-Resolution Tandem Mass-Spectrometry of Histone Isoforms' Hypermethylation Phenotype as a Hallmark Characteristic of Human-IDH-Mutant High-Grade Gliomas: Epigenetic Applications for Genotoxicity-Based Biomarkers and Cancer Therapy Targets

利用高分辨率串联质谱鸟枪法蛋白质组学鉴定组蛋白亚型高甲基化表型作为人类IDH突变型高级别胶质瘤的标志性特征:基于基因毒性的生物标志物和癌症治疗靶点的表观遗传学应用

阅读:2
作者:Kaouthar Louati,Fatma Kolsi,Manel Mellouli,Hanen Louati,Rania Zribi,Rim Kallel,Mahdi Borni,Yassine Gdoura,Leila Sellami Hakim,Amina Maalej,Sirine Choura,Mohamed Chamkha,Sami Sayadi,Basma Mnif,Zouheir Khemakhem,Tahya Sellami Boudawara,Mohamed Zaher Boudawara,Abderrahman Bouraoui,Jamil Kraiem,Fathi Safta

Abstract

Histone post-translational modifications (PTMs) have been linked to various pathological processes, especially in cancer onset, where they are envisaged as obvious diagnostic biomarkers and pivotal predictors for pathological prognosis. Consequently, their mapping and characterization constitute a critical field of study facilitated by recent advances in the high-throughput mass spectrometry technique. The current study aimed to clarify the neurotoxicity mechanisms at the epigenetic level induced by environmental stressors by examining their potential to induce aberrant histone methylation as it is the most involved modification in carcinogenesis. Our protocol first consisted of a 3D in vitro neurospheroid model derived from human high-grade gliomas, followed by treatment with a pesticide mixture. Furthermore, we analyzed histone isoform-digested peptides by shotgun proteomics with high-resolution tandem mass spectrometry, complemented by Western blotting to validate epigenetic changes. Our results revealed two major findings: First, histone demethylation in nontreated samples emphasizes the aggressiveness and poor prognosis of high-grade gliomas. Second, histone hypermethylation phenotype in treated samples underlies the adaptive strategy employed by cancer cells to overcome stress and promote progression, which is a hallmark characteristic of isocitrate dehydrogenase (IDH)-mutated gliomas. Hence, our findings not only help bridge the gap in knowledge about chromatin regulation but also pave the way for the development of targeted therapeutic approaches modulating histone hypermethylation in gliomas.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。